Yinzhi Wei

Featured in: Favicon

biomedcentral.com Favicon

bmccancer.biomedcentral.com

Articles

Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma | BMC Cancer | Full Text

May 21, 2024 | bmccancer.biomedcentral.com | Shaoping Liu |Lei Nie |Ze Tang |Qi Lu |Qun Liang |Yinzhi Wei

ReferencesGu Y, Guo Y, Gao N, et al. The proteomic characterization of the peritumormicroenvironment in human hepatocellular carcinoma[J]. Oncogene. 2022;41:2480–91. Article CAS PubMed PubMed Central Google Scholar de Castria TB, Khalil DN, Harding JJ, et al. Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma[J]. Future Oncol. 2022;18:3769–82. Article PubMed Google Scholar Broadfield LA, Duarte JAG, Schmieder R, et al.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →